TITLE

Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress

AUTHOR(S)
Balkan, J.; Dogru-Abbasoglu, S.; Kanbagli �.; �evikbas, U.; Ayka�-Toker, G.; Uysal, M.
PUB. DATE
May 2001
SOURCE
Human & Experimental Toxicology;May2001, Vol. 20 Issue 5, p251
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Thioacetamide (TAA) administration (0.3 g/l of tap water for a period of 3 months) to rats resulted in hepatic cirrhosis as assessed by biochemical and histopathological findings. This treatment caused an increase in the levels of malondialdehyde (MDA) and diene conjugates (DCs) and a decrease in the levels of glutathione (GSH), vitamin E, vitamin C and the activities of glutathione peroxidase (GSH-Px) in the liver of rats. Superoxide dismutase (SOD) activities were unchanged. Taurine (2% w/w, added to the chow diet) was administered together with TAA (0.3 g/l of drinking water) for 3 months. Taurine was found to decrease TAA-induced hepatic lipid peroxidation and to increase TAA-depleted vitamin E levels and GSH-Px activities. Histopathological findings also suggested that taurine has an inhibitive effect on TAA-induced hepatic cirrhosis. These results indicate that taurine treatment has a protective effect against TAA-induced liver cirrhosis by decreasing oxidative stress. Human & Experimental Toxicology (2001) 20, 251�254.
ACCESSION #
4886214

 

Related Articles

  • Prescribing Medications in Patients with Decompensated Liver Cirrhosis. Amarapurkar, Deepak N. // International Journal of Hepatology;2011, p1 

    Patients with decompensated liver cirrhosis have various serious complications which require multiple drugs for therapeutic or prophylactic use. Majority of the drugs are primarily metabolized and excreted by hepatobiliary system; hence, liver cell necrosis contributes to impaired drug handling...

  • Participation of aquaporin-1 in vascular changes and remodeling in cirrhotic liver. Iguchi, Hiroyoshi; Oda, Masaya; Yamazaki, Hitoshi; Yokomori, Hiroaki // Medical Molecular Morphology; 

    The pathophysiology of arterial capillary proliferation accompanying fibrosis in human cirrhosis remains unclear. However, evidence regarding the molecules participating in the pathophysiological process has been accumulating. Water channel proteins known as aquaporins (AQP)s, notably AQP-1,...

  • The Potential Effect of Special Formulas on Cirrhotic Rats. Hassan, Enayat M.; El-Kherbawy, Ghada M.; Ali, Mona A. M.; Dewidar, Omaima M. // Food & Nutrition Sciences;May2013, Vol. 4 Issue 5, p594 

    Liver protective effect of special formulas (1 and 2) was assessed against carbon tetra chloride (CCl4) which induced liver damage in Wister albino rats. The two prepared formulas reduced the changes in body weight and liver weight caused by CCl4 in rats. The toxicity of CCl4 is related to loss...

  • Five days of ceftriaxone to treat spontaneous bacterial peritonitis in cirrhotic patients. Franca, Alex Vianey Callado; Giordano, Helena maria; Sev �-Pereira, Tiago; Soares, Elza Cotrim // Journal of Gastroenterology;2002, Vol. 37 Issue 2, p119 

    Background. The aim of this study was to determine whether a short course of ceftriaxone was sufficient to cure spontaneous bacterial peritonitis (SBP) in cirrhotic patients. Methods. We studied 33 cirrhotic patients with SBP. All of them were treated with ceftriaxone, 1.0 g IV, every 12 h...

  • Treatment in primary biliary cirrhosis. Parkhouse, J. // British Medical Journal (Clinical Research Edition);10/10/1987, Vol. 295 Issue 6603, p867 

    Focuses on the treatment of primary biliary cirrhosis in Great Britain. Assessment of thyroid functions with fatigue; Benefits of cholestyramine treatment; Certainty on the efficacy of the treatment affecting important pathogenic factors.

  • Cirrhosis may be amenable to telomerase treatment. Berger, Abi // BMJ: British Medical Journal (International Edition);02/26/2000, Vol. 320 Issue 7234, p536 

    Provides information on a study in Boston, Massachusetts which suggested that liver disease culminating in cirrhosis may be amenable to telomerase treatment. Methods and subjects used in the study; Comments from Ron DePinho, research leader and professor of medicine and genetics at Harvard...

  • Terlipressin and arterial blood volume after paracentesis for tense ascites in cirrhosis. Ranger, G. Singh // Gut;Nov2002, Vol. 51 Issue 5, p755 

    Comments on a study published in a previous issue of the periodical 'Gut,' which described the use of terlipressin in ameliorating the reduction in effective arterial blood volume in patients with cirrhosis.

  • Silymarin: A Review of its Clinical Properties in the Management of Hepatic Disorders. Wellington, K.; Jarvis, B. // BioDrugs;2001, Vol. 15 Issue 7, p465 

    The mechanisms of action of silymarin involve different biochemical events, such as the stimulation of the synthetic rate of ribosomal RNA (rRNA) species through stimulation of polymerase I and rRNA transcription, protecting the cell membrane from radical-induced damage and blockage of the...

  • Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts. Kramer, Ludwig; Bauer, Edith; Gendo, Alexandra; Funk, Georg; Madl, Christian; Pidlich, Johann; Gangl, Alfred // American Journal of Gastroenterology;Jan2002, Vol. 97 Issue 1, p162 

    OBJECTIVES:We aimed to test the hypothesis that subclinical cognitive brain dysfunction in cirrhotic patients would deteriorate after a transjugular intrahepatic portosystemic shunt (TIPS) in the absence of clinically detectable hepatic encephalopathy.METHODS:Out of 49 consecutive cirrhotic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics